NGL Fine - Chem Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2040.05

-5.95 (-0.29%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2040.05

-5.95 (-0.29%)
16:02 Dec 20

Quality

66/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

48/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	257.97	317.5	278.08	338.69	371.94
Operating Expenses +	178.23	249.66	243.76	285.42	321.35
Raw Material	100.48	169.67	116.41	170.81	181.2
Increase Decrease in Cost	1.86	-22.68	23.91	-12.13	-1.29
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	28.09	34.85	36.87	45.12	50.25
Miscellaneous Expenses	47.8	67.82	66.57	81.62	91.19
Operating Profit	79.74	67.84	34.32	53.27	50.59
Other Income	8.02	10.68	5.53	14.13	18.36
Depreciation	8.33	10.37	11.29	11.64	11.89
Interest	1.84	1.56	1.2	1.34	1.53
Profit before tax and exceptio..	77.59	66.6	27.36	54.42	55.53
Exceptional Items	0	0	0	0	0
PBT	77.59	66.6	27.36	54.42	55.53
Provision for Taxation	20.87	16.7	6.87	13.1	14.16
Net Profit	56.72	49.9	20.5	41.32	41.38
NET Profit after MI	56.72	49.9	20.5	41.32	41.38
EPS	91.81	80.77	33.18	66.88	66.99
Operating Profit Margin (%)	30.91	21.37	12.34	15.73	13.6
Net Profit Margin (%)	21.99	15.72	7.37	12.2	11.13

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	72.70	72.70	72.70	73.10	73.10
FII	0.00	0.00	0.10	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	27.20	27.20	27.20	26.90	26.90
Others	0.10	0.10	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00